Yabao Pharmaceutical Group Co., Ltd (SHA:600351)

SHA:600351 Revenue

Yabao Pharmaceutical Group had revenue of 569.30M CNY in the quarter ending September 30, 2025, a decrease of -16.01%. This brings the company's revenue in the last twelve months to 2.27B, down -19.73% year-over-year. In the year 2024, Yabao Pharmaceutical Group had annual revenue of 2.69B, down -7.69%.

• Revenue (ttm): 2.27B
• Revenue Growth: -19.73%
• P/S Ratio: 2.06
• Revenue / Employee: 629.53K
• Employees: 3,611
• Market Cap: 4.68B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.69B	-223.73M	-7.69%
Dec 31, 2023	2.91B	191.63M	7.05%
Dec 31, 2022	2.72B	-45.83M	-1.66%
Dec 31, 2021	2.76B	161.54M	6.21%
Dec 31, 2020	2.60B	-439.49M	-14.45%